ConductScience.org, home

Paper24824136

Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.

Islam A and 8 others. Molecules, 2014. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages. Papers, record 24824136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24824136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.
PubMed
Journal
Molecules
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.01
iCite
Revised in PubMed
2021-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Islam AArshad
2Da Silva JGJeferson Gomes
3Berbet FMFilipe Moan
4da Silva SMSydnei Magno
5Rodrigues BLBernardo Lages
6Beraldo HHeloisa
7Melo MNMaria Norma
8Frézard FFrédéric
9Demicheli CCynthia

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
AntimonyMajor topic
Benzoic AcidMajor topic
Organometallic CompoundsMajor topic
Terphenyl CompoundsMajor topic
Animals
Leishmania infantum
Ligands
Macrophages
Mice
Pseudomonas aeruginosa
Staphylococcus aureus

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116354802A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.Am J Trop Med Hyg2005https://conductscience.org/library/papers/16354802PubMed
214720406Visceral leishmaniasis treatment, Italy.Emerg Infect Dis2003https://conductscience.org/library/papers/14720406PubMed
315504880Antimicrobial and antileishmanial activities of hypocrellins A and B.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15504880PubMed
43293160Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.Rev Infect Dis1988https://conductscience.org/library/papers/3293160PubMed
56606682Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J Immunol Methods1983https://conductscience.org/library/papers/6606682PubMed
612142292The world's most neglected diseases.BMJ2002https://conductscience.org/library/papers/12142292PubMed
71969794The amplified H circle of methotrexate-resistant leishmania tarentolae contains a novel P-glycoprotein gene.EMBO J1990https://conductscience.org/library/papers/1969794PubMed
821124518Green bismuth.Nat Chem2010https://conductscience.org/library/papers/21124518PubMed
917624846Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.J Infect Dis2007https://conductscience.org/library/papers/17624846PubMed
1019633606Pentavalent antimonials: new perspectives for old drugs.Molecules2009https://conductscience.org/library/papers/19633606PubMed
1124412095Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites.J Inorg Biochem2014https://conductscience.org/library/papers/24412095PubMed
1224190067Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.Dalton Trans2014https://conductscience.org/library/papers/24190067PubMed
1317072466Further thoughts on the use of the name Leishmania (Leishmania) infantum chagasi for the aetiological agent of American visceral leishmaniasis.Mem Inst Oswaldo Cruz2006https://conductscience.org/library/papers/17072466PubMed
149146788The actions of bismuth in the treatment of Helicobacter pylori infection.Aliment Pharmacol Ther1997https://conductscience.org/library/papers/9146788PubMed
1524077559Anti-leishmanial activity of heteroleptic organometallic Sb(v) compounds.Dalton Trans2013https://conductscience.org/library/papers/24077559PubMed
1611049798Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.Clin Infect Dis2000https://conductscience.org/library/papers/11049798PubMed
1721629719Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis.PLoS Negl Trop Dis2011https://conductscience.org/library/papers/21629719PubMed
1812576280Pt(II) and Pd(II) derivatives of ter-butylsarcosinedithiocarbamate. Synthesis, chemical and biological characterization and in vitro nephrotoxicity.J Inorg Biochem2003https://conductscience.org/library/papers/12576280PubMed
1916282296A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya.Am J Trop Med Hyg2005https://conductscience.org/library/papers/16282296PubMed
2018200413The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model.Rev Soc Bras Med Trop2007https://conductscience.org/library/papers/18200413PubMed

See all 32 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
40520680Current developments of metal- and metalloid-based quinoline compounds as leishmanicidal agents.Front Chem2025https://conductscience.org/library/papers/40520680PubMed
40197919Brazilian red propolis as a potential antimicrobial additive in orthodontic primers.Braz Dent J2025https://conductscience.org/library/papers/40197919PubMed
39065571A Second Wind for Inorganic APIs: Leishmanicidal and Antileukemic Activity of Hydrated Bismuth Oxide Nanoparticles.Pharmaceutics2024https://conductscience.org/library/papers/39065571PubMed
37570891Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome.Molecules2023https://conductscience.org/library/papers/37570891PubMed
37446634New Complexes of Antimony(III) with Tridentate O,E,O-Ligands (E = O, S, Se, Te, NH, NMe) Derived from N-Methyldiethanolamine.Molecules2023https://conductscience.org/library/papers/37446634PubMed
34442914Incorporation of Arginine to Commercial Orthodontic Light-Cured Resin Cements-Physical, Adhesive, and Antibacterial Properties.Materials (Basel)2021https://conductscience.org/library/papers/34442914PubMed
33083613Preparation, structural elucidation and biocidal applications of trimethyltin(IV) complexes derived from substituted carboxylic acids.Heliyon2020https://conductscience.org/library/papers/33083613PubMed
25251194Current and potential applications of bismuth-based drugs.Molecules2014https://conductscience.org/library/papers/25251194PubMed
25076143Activity of antifungal organobismuth(III) compounds derived from alkyl aryl ketones against S. cerevisiae: comparison with a heterocyclic bismuth scaffold consisting of a diphenyl sulfone.Molecules2014https://conductscience.org/library/papers/25076143PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24824136

GET https://conductscience.org/api/papers/v1/24824136/references?page=2